State-Funded Consortium Provides More Access Statewide to Clinical Trials for Cancer

The University of Minnesota and the Mayo Clinic are partnering in order to bring experimental medications, treatment protocols, and prevention programs to rural parts of the state. The consortium will allow the two research giants to be able to bring new clinical trials to 18 medical sites across the state.

“We are geographically a pretty big state, even though we’re small in population,” Dr. Douglas Yee, Department of Medicine, told the Star Tribune. “There are a lot of patients in greater Minnesota who don’t have access to the things we’re doing here or at the Mayo Clinic.”

The consortium will be supported by $8 million funded by the state in last year's bonding bill.

Read more

Share this post

Related News

  • Pharmacology Grad Students Promote Passion for Science

    University of Minnesota Medical School Department of Pharmacology graduate students connected with kids and families at the Science Museum of Minnesota during the Women in Science & Engineering event, a hands-on science experience focused on female leaders working in a variety of scientific and engineering professions.

  • Welcome Nichole Klatt, PhD

    Dr. Klatt joins the Medical School from the University of Miami, where she was most recently an associate professor and vice-chair of research in the department of pediatrics, held the Adrienne Arsht Endowed Chair in Pediatric Clinical Research and was a member of the Sylvester Comprehensive Cancer Center.